Forecast & Rating4 analysts currently cover Vivos Therapeutics, of which 2 give a positive rating. The average price target is $2.12, about 438.5% upside from the current price of $0.39. Coverage is limited, so the data is for reference only. Data as of Jul 8, 2026; this does not constitute investment advice.
Jul 8, 2026
Price forecast
$2.12438.46%
Forecast & RatingBuy
3analysts
Strong buy66.67%
Buy0.00%
Hold33.33%
Sell0.00%
Strong sell0.00%
Strong buy
2
Buy
0
Hold
1
Sell
0
Strong sell
0
Target price forecast
Forecast baselineJul 19, 2026
Forecast met42.0%
Stock price$0.39
Average forecast price$5.5
Highest forecast price$7
Lowest forecast price$4
Average forecast price
$5.5
Highest forecast price
$7
Lowest forecast price
$4
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.